CD Bioparticles organizes and provides a list of nano-drugs that have been approved by the FDA and EMA for marketing and clinical research in recent years for reference in new drug development.

Jan 4, 2025 · Notable examples of FDA-approved nanoparticle therapies include liposome-based Doxil, DaunoXome, Marqibo, Onpattro, and Vyxeos.

Information about FDA guidance documents on topics relating to the application of nanotechnology in FDA-related products.

A complete list of cancer nano-therapeutics approved by FDA and regulatory agencies of other countries is given below. Access a comprehensive list of the current U.S. clinical trials involving cancer …

Dec 16, 2025 · The FDA has approved over a dozen such therapies since 1995, including liposomes and albumin-bound nanoparticles, with ongoing trials expanding applications. These systems exploit …

Check out our FDA approved reference product description (US Food and Drug Administration) to have an overview of the product development pathway. We also added nanotherapeutics or nano drug …

Sep 10, 2025 · Learn how to navigate FDA nanomedicine regulations with guidance documents, market insights, and global strategies for successful development.

All of them have featured characterizations in the application of nanoparticle drug delivery systems, including biodegradability, biocompatibility and nontoxicity.

6 days ago · Novel Drug Approvals for 2025 What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S.

This review examines the revolutionary influence of nanotechnology on medical therapies, focusing on advancements, such as precise drug delivery, improved solubility, and responsive treatment systems.